Navigation Links
FDA Approves First Supplemental Test for Chagas Disease
Date:11/18/2011

SILVER SPRING, Md., Nov. 18, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to Trypanosoma cruzi (T. cruzi). T. cruzi causes Chagas disease, a serious and potentially fatal parasitic infection.

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

The test, called the ABBOTT ESA Chagas [Trypanosoma cruzi (E. coli, Recombinant) Antigen], is an in vitro enzyme strip assay for the qualitative detection of antibodies to T. cruzi. There are currently two donor screening tests licensed to detect antibodies to T. cruzi; however, this will be the first test licensed as a supplemental test.

"This test will help health care professionals to provide counseling to donors with positive screening test results," said Karen Midthun, M.D., director of the FDA's Center for Biologics Evaluation and Research.

Chagas disease is mainly spread by blood-sucking insects infected with T. cruzi. Chagas disease can also be spread through blood transfusion, organ transplants, and from mother to unborn child. The estimated number of persons living in the United States infected with T. cruzi, and at risk for developing Chagas disease, is 300,000 or more.

More than 5,000 donors with positive test results on a screening test have been identified since national screening of the blood supply was instituted in early 2007.

The Abbott ESA Chagas assay is manufactured by Abbott Laboratories, based in Abbott Park, Ill.

For more information:
Trypanosoma cruzi (T. cruzi) (Anti-T. cruzi Assay)
Complete List of Donor Screening Assays for Infectious Agents and HIV Diagnostic Assays

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

Media Inquiries: Shelly Burgess, 301-796-4651, shelly.burgess@fda.hhs.gov, Rita Chappelle, 301-796-4672, rita.chappelle@fda.hhs.gov
Consumer Inquiries: 888-INFO-FDA


'/>"/>
SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. FDA Approves Erwinaze to Treat a Form of Leukemia
2. FDA Approves New York Blood Centers HEMACORD™ for Stem Cell Transplantation
3. FDA Approves Erbitux to Treat Late-stage Head and Neck Cancer
4. FDA Approves Xarelto to Prevent Stroke in People With Common Type of Abnormal Heart Rhythm
5. FDA Approves U.S. Market Return for octagam® Following Octapharmas Implementation of Enhanced Safety Measures
6. FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
7. FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder
8. FDA Approves Onfi To Treat Severe Type of Seizures
9. FDA Approves Longer Duration Efficacy and Safety for EUFLEXXA®
10. FDA Approves Label Update for PREZISTA® to Include 192-Week Data in HIV-1-Infected Adult Patients Starting Treatment
11. FDA Approves Ferriprox to Treat Patients with Excess Iron in the Body
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... India , May 6, 2016 ... numbers of liver disorders along with rise in ... steatohepatitis) drugs in the coming few years. The ... over last five years on account of rising ... steatohepatitis) is a large, un-tapped market with no ...
(Date:5/5/2016)... First quarter 2016 adjusted diluted earnings per share (EPS) of ... First quarter reported diluted (GAAP) loss per share from continuing ... financial guidance; now expects 2016 revenues to range from $3.87 ... per share to range from $4.50 to $4.80 ... facility restructuring , Company expands Board capabilities, ...
(Date:5/5/2016)... 2016 Research and Markets has announced the ... 5 EU Markets"  report to their offering.  ,     (Logo: ... on the current Positron Emission Tomography (PET) scanner and cyclotron ... which includes France , Germany ... and the United Kingdom . ...
Breaking Medicine Technology:
(Date:5/6/2016)... ... May 06, 2016 , ... ... fat areas around the body, is the most popular among body sculpting options, ... make perfect sense to cosmetic surgeon Dr. Richard Buckley, medical director of MilfordMD ...
(Date:5/6/2016)... ... 06, 2016 , ... Online HR/benefits platforms offer a range of benefits functions ... brokers and health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies for ... Inc. (AIS), will offer an accurate picture of online benefits today, and the possible ...
(Date:5/6/2016)... , ... May 06, 2016 , ... From the Speaker ... Presence Technology will share its insights on managing Customers Engagement at SpeechTek 2016 ... SpeechTek 2016, Presence Technology will deliver a Presentation on “5 Customer Engagement ...
(Date:5/6/2016)... ... May 06, 2016 , ... The International Yoga Teacher Training ... end of the island close to the town famous for its sunsets, Oia. This ... , “We continue to have an amazing experience in Greece, we just can’t stay ...
(Date:5/6/2016)... ... May 06, 2016 , ... Multiple award winning plumbing company ... over 35 years. Maintaining core values of exceptional customer service, quality work at reasonable ... a leading name in San Diego plumbing, and other services including heating & air ...
Breaking Medicine News(10 mins):